v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
OPERATING CASH FLOW ACTIVITIES:    
Net loss $ (7,254) $ (26,791)
Reconciliation of net loss to net cash used in operating activities    
Depreciation 76 78
Accretion of debt discount and amortization of financing costs 350 43
Change in fair value of derivative liabilities (6,559) (30)
Stock-based compensation expense 180 3,433
Payable-in-kind interest on Credit Agreement 2,668 1,216
Operating lease right-of-use assets 79 75
Changes in operating assets and liabilities    
Accounts receivable 131 (307)
Inventory 37 (448)
Prepaid expenses, other current assets and other assets 608 901
Accounts payable, accrued expenses, due to related parties, and other current liabilities (2,269) 4,826
Accrued interest   (619)
Operating lease liabilities (90) (83)
Net cash used in operating activities (12,043) (17,706)
FINANCING CASH FLOW ACTIVITIES:    
Proceeds from issuance of common stock and warrants 14,006 26,743
Offering costs for common stock and warrants issuance (803) (117)
Payment of employee tax obligations related to vesting restricted stock units (1)  
Net cash provided by financing activities 13,202 26,626
Net increase in cash and cash equivalents 1,159 8,920
Cash and cash equivalents, beginning of the period 29,854 65,221
Cash and cash equivalents, end of the period $ 31,013 74,141
Supplemental cash flow information:    
Issuance of stock purchase warrants   $ 224